Literature DB >> 31813745

Genetic Testing in Inherited Heart Diseases.

Jodie Ingles1, Ivan Macciocca2, Ana Morales3, Kate Thomson4.   

Abstract

Inherited heart diseases include numerous conditions, from the more prevalent hypertrophic cardiomyopathy (HCM) and familial hypercholesterolaemia (FH), to the comparatively less common inherited arrhythmia syndromes, such as long QT syndrome (LQTS), catecholaminergic polymorphic ventricular tachycardia (CPVT) and Brugada syndrome (BrS). Genetic testing has evolved rapidly over the last decade and is now considered a mainstream component of clinical management of inherited heart diseases. Cardiac manifestations can also be part of wider syndromes, and genetic testing can play a critical role in clarifying the underlying aetiological basis of disease in some cases. The greatest utility of a genetic diagnosis, however, comes from the ability to elucidate disease risk amongst asymptomatic at-risk family members. Given the nuances and challenges, cardiac genetic testing is best performed in a multidisciplinary specialised clinic with access to cardiac genetic counselling.
Copyright © 2019 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Genetic counselling; Genetic testing; Inherited heart diseases

Mesh:

Year:  2019        PMID: 31813745     DOI: 10.1016/j.hlc.2019.10.014

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  8 in total

Review 1.  Sudden cardiac death-update.

Authors:  P Markwerth; T Bajanowski; I Tzimas; R Dettmeyer
Journal:  Int J Legal Med       Date:  2020-12-21       Impact factor: 2.686

2.  Precise in vivo functional analysis of DNA variants with base editing using ACEofBASEs target prediction.

Authors:  Alex Cornean; Jakob Gierten; Bettina Welz; Juan Luis Mateo; Thomas Thumberger; Joachim Wittbrodt
Journal:  Elife       Date:  2022-04-04       Impact factor: 8.713

3.  The Impact of Proband Indication for Genetic Testing on the Uptake of Cascade Testing Among Relatives.

Authors:  Tara J Schmidlen; Sara L Bristow; Kathryn E Hatchell; Edward D Esplin; Robert L Nussbaum; Eden V Haverfield
Journal:  Front Genet       Date:  2022-06-16       Impact factor: 4.772

Review 4.  Arrhythmogenic Right Ventricular Cardiomyopathy: The Role of Genetics in Diagnosis, Management, and Screening.

Authors:  Mihir Odak; Steven Douedi; Anton Mararenko; Abbas Alshami; Islam Elkherpitawy; Hani Douedi; Eran Zacks; Brett Sealove
Journal:  Cardiol Res       Date:  2022-08-15

Review 5.  Barriers to genetic testing in clinical psychiatry and ways to overcome them: from clinicians' attitudes to sociocultural differences between patients across the globe.

Authors:  Justo Pinzón-Espinosa; Marte van der Horst; Janneke Zinkstok; Jehannine Austin; Cora Aalfs; Albert Batalla; Patrick Sullivan; Jacob Vorstman; Jurjen J Luykx
Journal:  Transl Psychiatry       Date:  2022-10-11       Impact factor: 7.989

Review 6.  Ten things to know about ten cardiovascular disease risk factors.

Authors:  Harold E Bays; Pam R Taub; Elizabeth Epstein; Erin D Michos; Richard A Ferraro; Alison L Bailey; Heval M Kelli; Keith C Ferdinand; Melvin R Echols; Howard Weintraub; John Bostrom; Heather M Johnson; Kara K Hoppe; Michael D Shapiro; Charles A German; Salim S Virani; Aliza Hussain; Christie M Ballantyne; Ali M Agha; Peter P Toth
Journal:  Am J Prev Cardiol       Date:  2021-01-23

Review 7.  Metabolomic Laboratory-Developed Tests: Current Status and Perspectives.

Authors:  Steven Lichtenberg; Oxana P Trifonova; Dmitry L Maslov; Elena E Balashova; Petr G Lokhov
Journal:  Metabolites       Date:  2021-06-26

8.  Genetic variants associated with inherited cardiovascular disorders among 13,131 asymptomatic older adults of European descent.

Authors:  Ingrid Winship; Eric Schadt; John J McNeil; Paul Lacaze; Robert Sebra; Moeen Riaz; Jodie Ingles; Jane Tiller; Bryony A Thompson; Paul A James; Diane Fatkin; Christopher Semsarian; Christopher M Reid; Andrew M Tonkin
Journal:  NPJ Genom Med       Date:  2021-06-16       Impact factor: 8.617

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.